{"name":"Naurex, Inc, an affiliate of Allergan plc","slug":"naurex-inc-an-affiliate-of-allergan-plc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Placebo-matching Rapastinel","genericName":"Placebo-matching Rapastinel","slug":"placebo-matching-rapastinel","indication":"Major depressive disorder (as adjunctive treatment)","status":"phase_3"}]}],"pipeline":[{"name":"Placebo-matching Rapastinel","genericName":"Placebo-matching Rapastinel","slug":"placebo-matching-rapastinel","phase":"phase_3","mechanism":"Rapastinel is an NMDA receptor modulator that enhances glutamatergic neurotransmission by potentiating NMDA receptor function to improve cognitive and psychiatric symptoms.","indications":["Major depressive disorder (as adjunctive treatment)","Cognitive impairment associated with schizophrenia"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPYmxXamQwdmxpNnk2SmZoRE1SZGNfYnR5Q2MtNTdrM1UtVE1uZjlFbktxeExCUWVQTFdQbXA5U3VWSG1jcFM5SEFlNXpIZGdRMjU2Z0VjbzJSRGZQTExCcEJYOHk1MDJxamgtS3kzbXM2MmNxcU5tYkZaMzFtVG5BM2ZCSUFNQk12RnlF?oc=5","date":"2018-09-19","type":"pipeline","source":"Mintz","summary":"Mintz Represents Naurex Inc. - Mintz","headline":"Mintz Represents Naurex Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQOVRQUklrczY2Yng3SEVpaVN1cE9id0FzUDNTSm5lcDd3NnZFbUgzMHVLdVNiVFlpMjluaC1xUk9RZHZ4M2lSTHZyZEplN0VkNHhvaGN5Q3cyT2k0eGljQkprQUFfeXVsWE1mcXVCWUZZSjNlMUhlNjYzbzNkdXpYbm05b0xBMmNYQkxnci1GMS13bFNSMGV1YVNXaGI1Q1BYc202OXZHTFZ4Zw?oc=5","date":"2015-08-31","type":"pipeline","source":"PR Newswire","summary":"Allergan Successfully Completes Naurex Acquisition - PR Newswire","headline":"Allergan Successfully Completes Naurex Acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQMWRFbkdnclotMF9FelVpcmJBZ0t0eFdidEpoUzFUd2szOFNOU3ZpeUx0Sy1wVnB0Vl82U2toQ2tLbkhDaHJOT00xRHA4SlZLNUM5NktWNEdITXZmNVhvVXBiMWlTTVgxWkxMZDFLQ0tybU45Vy00Sk1KSmt2LXZXRlhSMURGUXB2OXhLczZJcC16allLaGJ6MGtFS3pTeFBCZmdqSg?oc=5","date":"2015-07-27","type":"deal","source":"BioPharma Dive","summary":"Allergan buys Naurex for $560 million, nabs 2 antidepressants - BioPharma Dive","headline":"Allergan buys Naurex for $560 million, nabs 2 antidepressants","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxQa0QwbXM0NUYtRl9ZRzRUYlpBYmlUMWRFZjYtYmpCeW52VUN1bVByRGw1U2lnYzRXb0xuMWlvaEZZdEk2Q3FkN29IaUNKa0c5TzlSdGpQSU9CNE5xUl9BQ0xOM3huRW53WmJOTVNQbDAzQTJWQWVUMWxVSGdHSzYzWExsQTh0SFRsc3c?oc=5","date":"2015-07-26","type":"deal","source":"PR Newswire","summary":"Allergan to Acquire Naurex - PR Newswire","headline":"Allergan to Acquire Naurex","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE5tZy15Sjh5Q3VVRldXOWEzcDlSbG1nb0Z3Slk3OWhxUXhhbHBJc3lDY2pLSUJ6N1JqVGdjTUdBU0dqamlPdFNoX0ppMXlZeEk5OWRkZzZjdlRDX2huYlNMcWF0T2U4d0ItR1JaVUw4aEU?oc=5","date":"2015-07-26","type":"deal","source":"Evanston Now","summary":"Allergan to acquire Evanston drug firm - Evanston Now","headline":"Allergan to acquire Evanston drug firm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQTGJPV3VzTzJrR1pLQ0YwclZpdldmbmNxcmZRUHBDQjlXY3BuZXU3WWczRVc3N1VYYkM5UTd6T25ZUjd5dkJNMlVsVl8zQkNldzE1Vk5td3RXRDFucmNiSzJubFNvYXYxdjdPdVFKMEgtalk4eHd6TEF1S3FQemxaajhlQlZoLV9VUTlNY3I4czY?oc=5","date":"2015-07-26","type":"deal","source":"WSJ","summary":"Allergan to Acquire Naurex for $560 Million Cash - WSJ","headline":"Allergan to Acquire Naurex for $560 Million Cash","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}